Investigating the Ku70 (XRCC6) gene polymorphism in patients with gastric cancer

Abstract

BACKGROUND The DNA repair gene Ku70, a key component of the non-homologous end-joining repair pathway, plays a crucial role in the repair of DNA double strand breaks (DSBs). Deficiencies in DSB repair may result in permanent genomic instability. However, the association between polymorphic variations of Ku70 and susceptibility to gastric cancer remains unclear. OBJECTIVE This study aims to investigate the potential correlation between the Ku70 promoter G-57C (rs2267437) and intron 3 (rs132774) polymorphisms and the risk of developing gastric cancer in the Turkish population. METHOD A hospital-based case-control study was conducted, including 92 patients diagnosed with gastric cancer and 194 age- and gender-matched healthy controls. Genotyping of Ku70 promoter G-57C (rs2267437) and intron 3 (rs132774) polymorphisms was performed using real-time PCR at Dokuz Eylül University Hospital, Izmir. RESULTS No significant difference was observed in the distribution of genotype frequencies for either polymorphism between the gastric cancer patients and the control group. The Chi-Square test revealed no significant difference in the frequencies of the G-57C (rs2267437) polymorphism between the cancer group and the control group. The CC genotype was absent in the cancer group, while it was present in one in the control group. The GG genotype of intron 3 (rs132774) polymorphism was also absent in both groups. The Chi-Square test revealed no significant difference between the two groups. CONCLUSION The presence of the Ku70 promoter G-57C (rs2267437) and intron 3 (rs132774) polymorphisms does not appear to increase the risk of gastric cancer in the Turkish population.

Keywords

• Case-control study
• DNA repair
• gastric cancer
• Ku70 gene
• polymorphisms

References

1. 1. Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterology Clinics of North America. 2013 Jun;42(2):219-40.
2. 2. Yang MD, Wang HC, Chang WS, Tsai CW, Bau DT. Genetic polymorphisms of DNA double strand break gene Ku70 and gastric cancer in Taiwan. BMC Cancer. 2011;11:174. PubMed PMID: 21575261.
3. 3. Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR, et al. A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. Annals of Surgical Oncology. 2008 Feb;15(2):514-8.
4. 4. Yamamoto S. Cancer statistics Digest. Trends of all cancer in Japan [News]. Japanese Journal of Clinical Oncology. 2001 Jun;31(6):294-6.
5. 5. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. Journal of Clinical Epidemiology. 2003 Jan;56(1):1-9.
6. 6. Torres J, Correa P, Ferreccio C, Hernandez-Suarez G, Herrero R, Cavazza-Porro M, et al. Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America. Cancer Causes & Control. 2013 Feb;24(2):249-56.
7. 7. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Annals of Surgical Oncology. 2010 Dec;17(12):3077-9.
8. 8. Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. Journal of Surgical Oncology. 2013 Mar;107(3):230-6.

9. 9. Bonequi P, Meneses-Gonzalez F, Correa P, Rabkin CS, Camargo MC. Risk factors for gastric cancer in Latin America: a meta-analysis. Cancer Causes & Control. 2013 Feb;24(2):217-31.
10. 10. Mizuno S, Miki I, Ishida T, Yoshida M, Onoyama M, Azuma T, et al. Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Digestive Diseases and Sciences. 2010 Nov;55(11):3132-7.
11. 11. Kang Y, Zhang J, Sun P, Shang J. Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer. International Journal of Clinical Oncology / Japan Society of Clinical Oncology. 2012 Apr 12.
12. 12. Ito H, Inoue H, Sando N, Kimura S, Gohda K, Sato J, et al. Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study. BMC Cancer. 2012;12:346.
13. 13. Zhang JF, Zhang JG, Kuai XL, Zhang H, Jiang W, Ding WF, et al. Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2'-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells. Experimental and Therapeutic Medicine. 2013 Mar;5(3):735-41.
14. 14. Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, et al. Somatic mutations and deletions of the e-cadherin gene predict poor survival of patients with gastric cancer. Journal of Clinical Oncology. 2013 Mar 1;31(7):868-75.
15. 15. Furgason JM, Bahassi el M. Targeting DNA repair mechanisms in cancer. Pharmacology & Therapeutics. 2013 Mar;137(3):298-308.
16. 16. Mondal P, Datta S, Maiti GP, Baral A, Jha GN, Panda CK, et al. Comprehensive SNP scan of DNA repair and DNA damage response genes reveal multiple susceptibility loci conferring risk to tobacco associated leukoplakia and oral cancer. PloS One. 2013;8(2):e56952.
17. 17. Kutuzov MM, Khodyreva SN, Ame JC, Ilina ES, Sukhanova MV, Schreiber V, et al. Interaction of PARP-2 with DNA structures mimicking DNA repair intermediates and consequences on activity of base excision repair proteins. Biochimie. 2013 Jan 26.
18. 18. Maria Berra C, Santos de Oliveira C, Carriao Machado Garcia C, Ribeiro Reily Rocha C, Koch Lerner L, Carmo de Andrade Lima L, et al. Nucleotide excision repair activity on DNA damage induced by photoactivated methylene blue. Free Radical Biology & Medicine. 2013 Apr 5.
19. 19. Hardy PO, Chaconas G. The nucleotide excision repair system of B. burgdorferi is the sole pathway involved in repair of DNA damage by UV light. Journal of Bacteriology. 2013 Mar 8.